1996
DOI: 10.1016/s0140-6736(96)91208-8
|View full text |Cite
|
Sign up to set email alerts
|

Basal cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
106
0
7

Year Published

1999
1999
2006
2006

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 130 publications
(113 citation statements)
references
References 23 publications
0
106
0
7
Order By: Relevance
“…The prevalence is roughly 1 in 56 000. 8 In most cases, the abnormality represents a mutation in the human homologue of the Drosophila patched gene (PTCH). 25 Perturbation of this tumor suppressor gene on chromosome 9 q22-q31 26,27 results in upregulated cell proliferation.…”
Section: Clinical Featuresmentioning
confidence: 99%
See 4 more Smart Citations
“…The prevalence is roughly 1 in 56 000. 8 In most cases, the abnormality represents a mutation in the human homologue of the Drosophila patched gene (PTCH). 25 Perturbation of this tumor suppressor gene on chromosome 9 q22-q31 26,27 results in upregulated cell proliferation.…”
Section: Clinical Featuresmentioning
confidence: 99%
“…7 Typically, BCCs occur in the fourth decade of life and beyond 8 although exceptions to this occur, in particular in the setting of specific genodermatoses or in patients with immune compromise. 9 As sun exposure plays a role in the development and transformation of BCC, 7 patients with light skin phenotypes are particularly predisposed as expected; this includes in the context of blue eyes, red hair and easy freckling 8 as well as those whose occupational or leisure activities lead them to pronounced and prolonged sun exposure. Additional risk factors for BCC include the exposure to arsenic, coal tar derivatives and irradiation, although by far ultraviolet (UV) light is the most important factor in lesion development and progression.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations